Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 12 Breast Neoplasms 11 Prostatic Neoplasms 10 Glioblastoma 10 Oropharyngeal Neoplasms 7 Rectal Neoplasms 6 Neoplasms 6 Lung Neoplasms 6 Astrocytoma 6 Squamous Cell Carcinoma of Head and Neck 5 Urinary Bladder Neoplasms 4 Burkitt Lymphoma 4 Adenocarcinoma of Lung 4 Pancreatic Neoplasms 3 Nasopharyngeal Carcinoma 3 Mouth Neoplasms 3 Lymphoma, Follicular 3 Hodgkin Disease 3 Gliosarcoma 3 Glioma 3 Esophageal Neoplasms 3 Carcinoma, Squamous Cell 3 Carcinoma 3 Triple Negative Breast Neoplasms 2 Sarcoma 2 Rhabdomyosarcoma 2 Neoplasm, Residual 2 Mesothelioma, Malignant 2 Meningeal Carcinomatosis 2 Lymphoma, Large B-Cell, Diffuse 2

Interventions

Radiotherapy 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Cancer Metastatic × Radiotherapy × 30 days × Clear all

NCT06859801 2026-06-05

TRIBUTE

Society of Interventional Oncology

Bone Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡